in general , the severity of adverse events was greater for the patients treated with erythromycin , necessitating the discontinuation of therapy in 8 ( 6.7 % ) patients treated with erythromycin as opposed to 1 ( 0.8 % ) patient treated with clarithromycin .
C0014806
erythromycin
C0055856
clarithromycin